Author
Philip J. Gold
Also Known As
P GOLD, P Gold, P J Gold, P. Gold, P. J. Gold, P.J. Gold, Philip Gold, Philip J Gold, Philip J Gold,, Philip J. Gold
94
Publications
3.6K
Citations
26
H-Index
48
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 16 | 20 | 1.7K |
2 | Immunology | 7 | 7 | 324 |
3 | Hepatology | 4 | 4 | 639 |
4 | Health Sciences | 2 | 2 | 45 |
5 | Gastroenterology | 2 | 2 | 28 |
Philip J. Gold
×
32
Publications
3.1K
Citations
24
H-Index
| Year | Citations | |
|---|---|---|
2006 | 536 | |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2005 | 261 | |
1987 | 219 | |
2013 | 192 | |
2020 | 186 | |
2011 | 167 | |
2003 | 150 | |
2006 | 110 | |
2004 | 96 |
Page 1
Page 1